Novobrantseva T, Manfra D, Ritter J, Razlog M, O'Nuallain B, Zafari M, Nowakowska D, Basinski S, Phennicie RT, Nguyen PA, Brehm MA, Sazinsky S, Feldman I. Preclinical Efficacy of VTX-0811: A Humanized First-in-Class PSGL-1 mAb Targeting TAMs to Suppress Tumor Growth. Cancers (Basel). 2024 Aug 06; 16(16).